MITOXANTRONE AS 1-SALVAGE CHEMOTHERAPY IN RELAPSED BREAST-CANCER

被引：6

作者：

BRAMBILLA, C

MOLITERNI, A

CODAZZI, D

VILLANI, F

CRIPPA, F

BONADONNA, G

机构：

[1] IST NAZL TUMORI,DIV CARDIOL,VIA G VENEZIAN 1,I-20133 MILAN,ITALY

[2] IST NAZL TUMORI,DIV NUCL MED,I-20133 MILAN,ITALY

[3] DIV MED ONCOL,MILAN,ITALY

来源：

TUMORI | 1989年 / 75卷 / 02期

关键词：

D O I：

10.1177/030089168907500213

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：145 / 149

页数：5

共 25 条

[11]

HENDERSON IC, 1987, SEMIN ONCOL, V14, P34

[12]

LANDYS K, 1985, INVEST NEW DRUG, V3, P133

[13] EARLY DETECTION OF DOXORUBICIN CARDIOTOXICITY BY M-MODE ECHOCARDIOGRAPHY [J].

MARKIEWICZ, W ;

ROBINSON, E ;

PELED, B ;

KAUFMAN, S ;

CARTER, A .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1980, 5 (02) :119-125

[14] SENSITIVITY AND SPECIFICITY OF RADIONUCLIDE EJECTION FRACTIONS IN DOXORUBICIN CARDIOTOXICITY [J].

MCKILLOP, JH ;

BRISTOW, MR ;

GORIS, ML ;

BILLINGHAM, ME ;

BOCKEMUEHL, K .

AMERICAN HEART JOURNAL, 1983, 106 (05) :1048-1056

[15] MITOXANTRONE AS 1ST-LINE CHEMOTHERAPY IN ADVANCED BREAST-CANCER - RESULTS OF A COLLABORATIVE EUROPEAN STUDY [J].

MOURIDSEN, HT ;

CORNBLEET, M ;

STUARTHARRIS, R ;

SMITH, I ;

COLEMAN, R ;

RUBENS, R ;

MCDONALD, M ;

RAINER, H ;

VANOOSTEROM, A ;

SMYTH, J .

INVESTIGATIONAL NEW DRUGS, 1985, 3 (02) :139-148

[16] A COMPARISON OF MITOXANTRONE AND DOXORUBICIN IN BREAST-CANCER [J].

NEIDHART, JA ;

GOCHNOUR, D ;

ROACH, R ;

HOTH, D ;

YOUNG, D .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (05) :672-677

[17]

SCHELL FC, 1984, CANCER TREAT REP, V66, P1641

[18]

SCHENKENBERG TD, 1986, ANN INTERN MED, V105, P67

[19]

SCHENKENBERG TD, 1986, CANCER TREAT REP, V70, P659

[20]

SMITH IE, 1983, CANCER TREAT REV, V10, P103, DOI 10.1016/0305-7372(83)90008-7

← 1 2 3 →